Annual accounts
Total Exemption Full accounts
31/03/2027Filing deadline
- Next accounts made up to
- 30/06/2026
- Last accounts made up to
- 30/06/2025
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Appointment of Mr Timothy James Precious as a director on 2026-05-26
Appointment of Mr Noel Waters as a director on 2025-06-19
Termination of appointment of Noel Waters as a director on 2025-06-19
Confirmation statement made on 2026-02-11 with updates
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Total Exemption Full accounts
31/03/2027Filing deadline
Confirms the registry record is up to date
25/02/2027Filing deadline
The latest figures NUVISION BIOTHERAPIES LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
2024: £-177.05K
Total Assets
2024: £446.41K
Cash in Bank
2024: £44.29K
Total Liabilities
2024: £608.02K
Employees
2024: 21
Of the 4 measures with an earlier filing to compare against, 3 rose and 1 fell. Net assets moved furthest, up 708.94% on 2024. See the full financial analysis for NUVISION BIOTHERAPIES LIMITED.
The full financial record
Four ways through NUVISION BIOTHERAPIES LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 26 | +5 |
| 2024 | 21 | +3 |
| 2023 | 18 | +4 |
| 2022 | 14 | +1 |
| 2021 | 13 | – |
Reported employee count increased from 13 in 2021 to 26 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Corporate Director | 26/11/2020–Present | 153 | |
| Director | 19/01/2018–31/03/2026 | 18 | |
| Director | 07/04/2015–20/05/2015 | 48 | |
| Director | 01/03/2018–Present | 29 | |
| Director | 26/05/2026–Present | 12 | |
| Director | 08/07/2015–16/10/2017 | 8 | |
| Director | 20/05/2015–Present | 1 | |
| Director | 08/07/2015–14/12/2015 | 0 | |
| Director | 08/07/2015–14/12/2015 | 1 | |
| Director | 19/12/2019–28/04/2021 | 0 | |
| Director | 20/05/2015–31/05/2018 | 2 | |
| Corporate Director | 08/07/2015–24/05/2019 | 0 | |
| Director | 17/09/2020–19/05/2022 | 6 | |
| Director | 20/01/2022–31/12/2025 | 15 | |
| Director | 08/07/2015–31/03/2018 | 10 | |
| Director | 24/05/2019–26/11/2020 | 5 | |
| Director | 19/06/2025–19/06/2025 | 0 | |
| Director | 19/06/2025–Present | 19 |
Every document on the Companies House record, newest first.
Appointment of Mr Timothy James Precious as a director on 2026-05-26
Appointment of Mr Noel Waters as a director on 2025-06-19
Termination of appointment of Noel Waters as a director on 2025-06-19
Confirmation statement made on 2026-02-11 with updates
Termination of appointment of Jonathan Mark Treherne as a director on 2026-03-31
Total exemption full accounts made up to 2025-06-30
Termination of appointment of Andrew Hill as a director on 2025-12-31
Appointment of Mr Noel Waters as a director on 2025-06-19
Appointment of Mr Timothy John Gray as a director on 2025-06-19
Statement of capital following an allotment of shares on 2025-03-25
Confirmation statement made on 2025-02-11 with updates
Total exemption full accounts made up to 2024-06-30
Showing 12 of 28 filings
See when the next accounts and confirmation statement are due
6 UK companies are similar to NUVISION BIOTHERAPIES LIMITED, sharing the same company status (Active), the same industry sector and activity group (Manufacture of pharmaceutical preparations) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
6th Floor Napier House, 24 High Holborn, London WC1V 6AZ
9 Cardinal Park, Godmanchester, Huntingdon, Cambridgeshire PE29 2XG
C/O BIO-TECH SOLUTIONS LIMITED, Kelleythorpe Industrial Estate Kelleythorpe Industrial Estate, Kellythorpe, Driffield, North Humberside YO25 9DJ
One, Glass Wharf, Bristol BS2 0ZX
34-35 Woodley Precinct, Woodley, Stockport SK6 1RJ
A short description of the company, written from its Companies House record.
NUVISION BIOTHERAPIES LIMITED is a private limited company registered in the United Kingdom, based in Medicity, D6 Building, Thane Road, Nottingham NG90 6BH. Companies House classifies its business as Manufacture of pharmaceutical preparations. It has been on the register for 11 years 5 months.
The register currently records it as active. Its 2025 accounts report net assets of £1.08M and 26 employees.
Answered from this company's own registry record and filed figures.
Companies House records NUVISION BIOTHERAPIES LIMITED under one registered business activity: Manufacture of pharmaceutical preparations (21.20 - SIC 2007).
NUVISION BIOTHERAPIES LIMITED is recorded as active on the Companies House register, and has been on it since 07/04/2015.
The most recent accounts Okredo holds cover 2025 and report net assets of £1.08M, total assets of £1.47M, cash in bank of £928.80K and total liabilities of £360.45K.
The most recent document on the record is dated 19/06/2026: Appointment of Mr Timothy James Precious as a director on 2026-05-26, 3 months ago.
On the current registry record, accounts are due by 31/03/2027 and the next confirmation statement is due by 25/02/2027.
Companies House lists 18 officers (5 currently in post) and 0 people with significant control.